Literature DB >> 24994629

Biomedicine. Faulty drug trials tarnish Japan's clinical research.

Dennis Normile.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24994629     DOI： 10.1126/science.345.6192.17

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  4 in total

1.  Implementation of Japan's First Clinical Research Regulatory Law: Background, Overview, and Challenges.

Authors:  Akira Akabayashi; Eisuke Nakazawa; Aru Akabayashi
Journal:  HEC Forum       Date:  2019-12

2.  Misconduct: Japan to learn from biomedical cases.

Authors:  Tetsuya Tanimoto; Masahiro Kami; Kenji Shibuya
Journal:  Nature       Date:  2014-08-28       Impact factor: 49.962

Review 3.  A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan.

Authors:  Tetsuya Tanimoto
Journal:  Drug Des Devel Ther       Date:  2015-03-31       Impact factor: 4.162

4.  Scientific Misconduct and Social Media: Role of Twitter in the Stimulus Triggered Acquisition of Pluripotency Cells Scandal.

Authors:  Yuya Sugawara; Tetsuya Tanimoto; Shoko Miyagawa; Masayasu Murakami; Atsushi Tsuya; Atsushi Tanaka; Masahiro Kami; Hiroto Narimatsu
Journal:  J Med Internet Res       Date:  2017-02-28       Impact factor: 5.428
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.